Table 75.3Protective effect of neutralizing and ADCC antibody in limiting extent of neonatal HSV disease

Neonatal ADCC Neonatal neutralizing antibody titer
<1:5 (n=15) 1:5 to 1:20 (n=25) >1:20 (n=6)
SEM
1:104 to 1:106 2 6 3
0 to 1:103 4 2 2
CNS
1:104 to 1:106 2 5 0
0 to 1:103 0 9 0
Disseminated
1:104 to 1:106 0 0 0
0 to 1:103 7 3 1
a

From Kohl et al. (1989).

From: Chapter 75, Immunotherapy of HSV infections – antibody delivery

Cover of Human Herpesviruses
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis.
Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors.
Cambridge: Cambridge University Press; 2007.
Copyright © Cambridge University Press 2007.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.